AMN Healthcare Services, Inc. (AMN) 2023 Q3 法說會逐字稿

完整原文

使用警語:中文譯文來源為 AI 翻譯,僅供參考,實際內容請以英文原文為主

  • Operator

    Operator

  • Good day and thank you for standing by. Welcome to the AMN Healthcare Third Quarter 2023 Earnings Call. (Operator Instructions) Please be advised that today's conference is being recorded.

    各位好,感謝您耐心等候。歡迎參加 AMN Healthcare 2023 年第三季財報電話會議。(接線員指示)敬請注意,今日會議將進行錄音。

  • I would now like to hand the conference over to your first speaker today, Randy Reece, Senior Director of Investor Relations and Strategy. Please go ahead.

    現在我想把會議交給今天的第一位講者,投資人關係與策略資深總監 Randy Reece。請開始。

  • Randle G. Reece - Senior Director of IR & Strategy

    Randle G. Reece - Senior Director of IR & Strategy

  • Good afternoon, everyone. Welcome to AMN Healthcare's third quarter 2023 earnings call. A replay of this webcast will be available at ir.amnhealthcare.com at the conclusion of this call.

    各位下午好。歡迎參加 AMN Healthcare 2023 年第三季財報電話會議。本次網路直播的重播將於本通話結束後,於 ir.amnhealthcare.com 提供。

  • Various remarks we make during this call about future expectations, projections, trends, plans, events or circumstances constitute forward-looking statements. These statements reflect the company's current beliefs based upon information currently available to it. Our actual results may differ materially from those indicated by these forward-looking statements because of various factors and cautionary statements, including those identified in our most recently filed Forms 10-K and 10-Q, our earnings release and subsequent filings with the SEC. The company does not intend to update guidance or any forward-looking statements provided today prior to its next earnings release.

    我們在本次通話中就未來預期、預測、趨勢、計畫、事件或情況所作的各項評論,均構成前瞻性陳述。這些陳述反映公司基於目前可得資訊所持有的當前信念。由於各種因素及警示性陳述(包括我們最近提交的 10-K 與 10-Q 表格、財報新聞稿以及其後向美國證券交易委員會(SEC)提交的文件中所識別者),我們的實際結果可能與這些前瞻性陳述所示存在重大差異。公司無意在下一次財報發布前更新今日提供的指引或任何前瞻性陳述。

  • This call contains certain non-GAAP financial information. Information regarding and reconciliations of these non-GAAP measures to the most directly comparable GAAP measures are included in our earnings release and on our financial reports page at ir.amnhealthcare.com.

    本次通話包含若干非 GAAP 財務資訊。關於這些非 GAAP 指標的資訊,以及其與最直接可比之 GAAP 指標的調節表,已載於我們的財報新聞稿,並可於 ir.amnhealthcare.com 的財務報告頁面查閱。

  • On the call today are Cary Grace, President and Chief Executive Officer; and Jeff Knudson, Chief Financial Officer.

    今天參與通話的有:總裁兼執行長 Cary Grace,以及財務長 Jeff Knudson。

  • I will now turn the call over to Cary.

    現在我將把通話交給 Cary。

  • Caroline Sullivan Grace - President, CEO & Director

    Caroline Sullivan Grace - President, CEO & Director

  • Thank you, Randy, and welcome everyone. As the health care sector tries to find post-pandemic normal for demand and costs, managing labor costs while building a sustainable workforce has been a major theme in health care for 2023. Amidst extraordinary staffing challenges during the pandemic, health care employers struggled to keep up with hiring needs and used contingent labor to bridge the gap. Health care organizations have made significant progress in hiring permanent workers and this has been felt across the staffing industry in the form of lower demand for travelers. We anticipated a market reset was coming, but it has been deeper and more sustained than we and the rest of the industry expected. At the same time, as clients think about building a more sustainable workforce, our broad and deep set of technology-enabled talent solutions has positioned us well to support clients as they redesign their own workforce mix and day-to-day operations.

    謝謝你,Randy,也歡迎各位。隨著醫療保健產業試圖在疫情後為需求與成本找到新的常態,如何在建立可持續的人力隊伍同時管理人力成本,已成為 2023 年醫療保健領域的重要主題。在疫情期間面臨前所未有的人力配置挑戰之下,醫療保健雇主難以滿足招募需求,並以臨時/派遣人力來彌補缺口。醫療保健機構在招募正式員工方面已取得顯著進展,這也反映在整個人力派遣產業上,表現為對「旅派」人員需求降低。我們預期市場將出現重置,但其幅度更深、持續時間也更長,超出我們以及產業其他同業的預期。同時,當客戶思考如何建立更可持續的人力隊伍時,我們廣泛且深厚、以科技賦能的人才解決方案組合,使我們能夠在客戶重新設計其人力組合與日常營運時,提供有力支援。

  • Third quarter revenue was in line with our expectations. Consistent with what the market is experiencing, third quarter revenue was 14% lower than Q2 and down 25% year-over-year. We expect the rate of sequential decline in revenue to be a mid-single-digit percentage for Q4, a slower decline than the prior 2 quarters. This outlook calls for a stable to slightly higher number of nurse and allied travelers on assignment, offset by lower bill rate and hours and seasonal declines in other businesses.

    第三季營收符合我們的預期。與市場整體情況一致,第三季營收較第二季下降 14%,較去年同期下降 25%。我們預期第四季營收的季減幅度將為中個位數百分比,較前兩季的降幅更為趨緩。此展望假設護理與醫事(allied)旅派人員在案量將持平至略增,但將被較低的計費費率(bill rate)與工時,以及其他業務的季節性下滑所抵銷。

  • While staffing demand varies from client-to-client, most clients are asking for help with more than temporary staffing. To that end, we have made solid progress on our 4 key priorities that we discussed at the beginning of the year to extend our leadership in total talent solutions. First, we have reinforced our position as the preferred partner to help health care organizations optimize their workforce strategy. We began the year with a strong push to reestablish more proactive relationships with clients after 3 years of crisis management. To serve all clients current and future needs, AMN has established an accelerated cadence of rolling out enhancements and innovations in our technology platform that will continue through the end of this year and beyond.

    雖然人力派遣需求因客戶而異,但多數客戶尋求的協助不僅是臨時派遣。為此,我們在年初所討論、用以延伸我們在整體人才解決方案(total talent solutions)領導地位的四項關鍵優先事項上,已取得扎實進展。第一,我們鞏固了作為首選合作夥伴的地位,協助醫療保健機構最佳化其人力策略。我們以強力行動展開新的一年,在經歷三年的危機管理後,重新與客戶建立更主動的關係。為滿足所有客戶當前與未來的需求,AMN 已建立加速節奏,持續推出我們科技平台的強化與創新,並將延續至今年年底及更長遠的未來。

  • After focusing on serving our MSP clients in a time of crisis, we are back to serving the broader market with the entirety of our solutions set. We are doing things that will greatly help us and our clients over the long-term, true innovation. Our connection with clients is accelerating in several ways. At the front end, we are making it easier to do business with AMN. This means empowering our client-facing team members with greater integration across our 20 solutions. We have strengthened our ability to deliver multifaceted tech-enabled workforce solutions that simplify labor management and provide a variety of options for making the labor force more flexible and cost-effective. Clients will be able to access our full set of solutions through our better integrated sales and service organization. This effort to simplify our client relationships includes a stepped up branding initiative that aims to drive greater recognition of the breadth and depth of our presence in the marketplace for health care workforce solutions. Recently, we announced that Staff Care and Merritt Hawkins have been consolidated under the AMN Physician Solutions brand. As we continue to integrate into the AMN brand across our businesses, we expect to produce many benefits for our health care professionals in current and prospective clients.

    在危機期間專注服務我們的 MSP 客戶之後,我們已回到以完整解決方案組合服務更廣泛的市場。我們正在推動真正的創新,這些作為將在長期大幅助益我們與客戶。我們與客戶的連結正以多種方式加速。在前端方面,我們正讓與 AMN 合作變得更容易。這意味著透過我們 20 項解決方案之間更高程度的整合,賦能面向客戶的團隊成員。我們強化了交付多面向、以科技賦能的人力解決方案的能力,藉此簡化人力管理,並提供多元選項,使勞動力更具彈性且更具成本效益。客戶將可透過我們整合度更高的銷售與服務組織,取得我們完整的解決方案組合。這項簡化客戶關係的努力,也包含加強品牌推廣計畫,旨在提升市場對我們在醫療保健人力解決方案領域之廣度與深度的認知。近期我們宣布,Staff Care 與 Merritt Hawkins 已整併至 AMN Physician Solutions 品牌之下。隨著我們持續在各項業務中整合至 AMN 品牌,我們預期將為我們的醫療專業人員以及現有與潛在客戶帶來多項效益。

  • Second, we have made strategic moves to ensure AMN is the preferred employer for health care professionals and team members. We have delivered greater workplace flexibility, aligned pay and benefits with market benchmarks, launched new career planning and mentoring support and reinforced our industry leadership in diversity, equality, equity and inclusion. Our team members are gaining empowerment from improved ease of processes, faster, more responsive team communications and the integration of AMN Passport, our industry-leading mobile app into our workflows. Passport continues its strong growth of registrants and average daily users. This growth is driven by the increasing value we are building into Passport for health care professionals. Our road map for Passport is to broaden its reach across the spectrum of health care occupations and job types. We are excited about the power that Passport is bringing to health care professionals and see it gaining momentum every day. Passport is only part of the promising results we have produced in improving the credentialing process and candidate experience.

    第二,我們採取策略性行動,確保 AMN 成為醫療專業人員與團隊成員的首選雇主。我們提供更高的職場彈性,使薪酬與福利與市場基準對齊,推出新的職涯規劃與導師支持,並強化我們在多元(diversity)、平等(equality)、公平(equity)與共融(inclusion)方面的產業領導地位。透過流程更簡便、團隊溝通更快速且更具回應性,以及將我們業界領先的行動 App「AMN Passport」整合進工作流程,我們的團隊成員正獲得更大的賦能。Passport 的註冊人數與平均每日使用者持續強勁成長。此成長來自我們持續為醫療專業人員在 Passport 中打造的更高價值。我們對 Passport 的路線圖,是將其觸及範圍擴展至更廣泛的醫療職類與工作型態。我們對 Passport 為醫療專業人員帶來的力量感到振奮,並看到其每天都在累積動能。Passport 只是我們在改善證照審核(credentialing)流程與候選人體驗方面所取得可喜成果的一部分。

  • Third, we have strengthened our portfolio of talent solutions in many ways, with our strong commitment to technology enablement of our One AMN initiative. We are more digitally connected. AMN already has launched powerful integrations and strong implementation and support capabilities that are essential to integrating our solutions into bigger tech stacks and into total workforce solutions. Over the next few quarters, our transformative efforts will make the value proposition across our solutions come to life.

    第三,透過對 One AMN 計畫之科技賦能的堅定承諾,我們在多方面強化了人才解決方案組合。我們的數位連結更緊密。AMN 已推出強大的整合功能,以及健全的導入與支援能力,這些對於將我們的解決方案整合進更大型的技術堆疊(tech stacks)與整體人力解決方案至關重要。在接下來幾個季度,我們的轉型努力將使各項解決方案的價值主張具體落地。

  • A major milestone in our digital acceleration is the go-live this month of ShiftWise Flex, the latest generation of our market-leading vendor management system that is trusted by many of the nation's largest health systems. The newly reengineered platform manages a full-range of program management options, as well as clinical and non-clinical labor sourcing options from agency staffing and independent contractors to float pool and direct hire. ShiftWise Flex empowers users with intuitive dashboard, real-time data-driven labor market insights, powerful supplier support and Passport integration for AI-powered talent matching, credentialing and candidate self-service. ShiftWise Flex is here at the right time as health systems seek faster and more powerful and transparent ways to develop sustainable workforce agility that delivers great outcomes for patients and their caregivers.

    我們數位加速的一項重要里程碑,是本月 ShiftWise Flex 正式上線。ShiftWise Flex 是我們市場領先之供應商管理系統(VMS)的最新一代版本,深受全美多家最大型醫療體系信賴。全新重新設計的平台可管理完整範圍的專案管理選項,以及臨床與非臨床的人力來源選項,涵蓋從人力派遣機構、獨立承包商到浮動人力池(float pool)與直接招募(direct hire)。ShiftWise Flex 透過直覺式儀表板、即時且以數據驅動的勞動市場洞察、強大的供應商支援,以及與 Passport 的整合(用於 AI 驅動的人才媒合、證照審核與候選人自助服務),賦能使用者。當醫療體系尋求更快速、更強大且更透明的方法,以建立可持續的人力敏捷性並為病患及其照護者帶來優異成果之際,ShiftWise Flex 在此刻推出正逢其時。

  • And fourth, we have continued to generate strong cash flows and put capital to work. Our capital expenditures this year are on track to reach a record high $100 million, focused primarily on innovations that we expect to bring attractive long-term returns. Last week, we announced plans to acquire MSDR, which will bolster our Locum Tenens growth strategy and present in attractive physician specialties. Accelerating our organic Locums growth with an acquisition has been a priority for us. And the expertise and track record of MSDR are strong complements to and growth accelerators for our existing Locums business. Our strong balance sheet and cash flows enable us to make acquisitions that improve the value we bring to all stakeholders.

    第四,我們持續創造強勁的現金流並有效運用資本。我們今年的資本支出可望達到創紀錄的 1 億美元,主要聚焦於我們預期可帶來具吸引力長期報酬的創新項目。上週,我們宣布計畫收購 MSDR,這將強化我們的 Locum Tenens(代班醫師)成長策略,並提升我們在具吸引力的醫師專科領域的布局。透過併購加速我們 Locums 業務的有機成長一直是我們的優先事項,而 MSDR 的專業能力與過往績效,將與我們既有的 Locums 業務形成強力互補並成為成長加速器。我們強健的資產負債表與現金流,使我們能夠進行併購,提升我們為所有利害關係人帶來的價值。

  • Across the AMN organization we are excited to have reached the stage of our progression. I have been honored to lead this extraordinary group of people from identifying needed changes to developing a growth map, accelerating our pace of innovation and delivering results, while simultaneously managing through a significant post-pandemic workforce reset. We have turned the sales engine back on for all market segments and have been rewarded with some early traction and wins. We are positioning AMN to win across all market segments as the market recovers. We are confident that the long-term investment thesis for AMN is attractive. The health care workforce faces structural constraints serving demand growth for care driven by an aging population. We are convinced that our tech-enabled services model will win and AMN is well positioned with valuable clients who need our depth and breadth of solutions. While the overall market continues to be challenging, our pace of positive change is accelerating and AMN is doing the right things to embrace all levels of our very large market opportunity.

    在整個 AMN 組織中,我們很振奮能夠走到目前的發展階段。我很榮幸能帶領這個非凡的團隊,從辨識所需的變革到制定成長藍圖、加速創新步伐並交付成果,同時也在疫情後顯著的醫療人力重置過程中穩健管理。我們已重新啟動所有市場區隔的銷售引擎,並獲得了一些早期動能與勝利。隨著市場復甦,我們正讓 AMN 在各個市場區隔具備致勝定位。我們相信 AMN 的長期投資論點具吸引力。醫療照護人力面臨結構性限制,難以滿足因人口老化所帶動的照護需求成長。我們深信以科技賦能的服務模式將會勝出,而 AMN 也憑藉需要我們解決方案深度與廣度的高價值客戶,處於有利位置。儘管整體市場仍具挑戰,我們正向變革的速度正在加快,AMN 正在做正確的事,以把握我們龐大市場機會的各個層面。

  • Now, I'll turn the call over to Jeff, who will review our latest financial results and outlook.

    接下來我把電話會議交給 Jeff,由他回顧我們最新的財務結果與展望。

  • Jeffrey R. Knudson - CFO, CAO & Treasurer

    Jeffrey R. Knudson - CFO, CAO & Treasurer

  • Thank you, Cary, and good afternoon, everyone. Third quarter revenue of $853 million was near the high-end of our guidance range, driven by outperformance in our Nurse and Allied segment. Consolidated revenue was down 25% from the third quarter of 2022. Sequentially, revenue was lower by 14% as the operating environment remained challenging with clients maintaining lower demand levels and lower bill rates within Nurse and Allied and VMS, as well as lower volumes across Physician and Leadership Solutions.

    謝謝你,Cary,各位下午好。第三季營收為 8.53 億美元,接近我們指引區間的上緣,主要受惠於護理與醫事專業(Nurse and Allied)部門表現優於預期。合併營收較 2022 年第三季下滑 25%。就季比而言,營收下滑 14%,因營運環境仍具挑戰,客戶維持較低需求水準,且護理與醫事專業與 VMS 的計費費率(bill rates)較低,同時醫師與領導力解決方案(Physician and Leadership Solutions)各業務量亦下降。

  • Gross margin for the quarter was 33.9%, slightly exceeding our guidance range. Compared with the prior year period, gross margin was up 10 basis points. Sequentially, gross margin increased 60 basis points, primarily due to the release of a workers compensation reserve.

    本季毛利率為 33.9%,略高於我們的指引區間。與去年同期相比,毛利率提高 10 個基點。就季比而言,毛利率增加 60 個基點,主要因釋放了工傷保險準備(workers compensation reserve)。

  • Consolidated SG&A expenses were $163 million or 19.1% of revenue compared with $215 million or 18.9% of revenue in the prior year period and $202 million or 20.4% of revenue in the previous quarter. Third quarter SG&A expenses were reduced by several favorable items that amounted to a benefit of $5 million. The decrease in SG&A expenses year-over-year was primarily due to lower employee expenses stemming from the current demand environment and lower bad debt reserve. Sequentially, lower employee expenses driven by lower business volumes and a decrease in non-recurring expenses led to the significant decrease in SG&A expenses. Adjusted SG&A which excludes certain non-recurring expenses and stock based compensation expense was $157 million in the third quarter or 18.4% of revenue, compared with $204 million or 17.9% of revenue in the prior year period and $170 million or 17.1% of revenue in the prior quarter. The increase in adjusted SG&A as a percentage of revenue both year-over-year and sequentially was primarily due to lower revenue.

    合併 SG&A 費用為 1.63 億美元,占營收 19.1%;去年同期為 2.15 億美元,占營收 18.9%;上一季為 2.02 億美元,占營收 20.4%。第三季 SG&A 費用因數項有利因素而降低,合計帶來 500 萬美元的利益。SG&A 費用年減主要來自於在目前需求環境下員工相關費用降低,以及呆帳準備較低。就季比而言,因業務量下降帶動員工費用降低,加上非經常性費用減少,使 SG&A 費用顯著下降。第三季調整後 SG&A(排除部分非經常性費用與股票基礎薪酬費用)為 1.57 億美元,占營收 18.4%;去年同期為 2.04 億美元,占營收 17.9%;上一季為 1.70 億美元,占營收 17.1%。調整後 SG&A 占營收比重無論年比或季比上升,主要是因營收較低。

  • In the third quarter, Nurse and Allied revenue was $573 million, down 31% from the year ago period. Sequentially, segment revenue was down 17%, driven by the continued trend of lower volume, hours and bill rates. Average bill rate was down 10% year-over-year and down 7% sequentially. Year-over-year volume was down 19% and average hours worked were down 4%. Sequentially, volume was down 12% and average hours were down 1%. Travel Nurse revenue for the third quarter was $384 million, a decrease of 34% in the prior year period and 20% from the prior quarter. Allied revenue during the quarter was $168 million, down 12% year-over-year and 8% sequentially. Nurse and Allied gross margin during the third quarter was 27.5%, which increased 50 basis points from the prior year period and 80 basis points sequentially. A benefit of 40 basis points came from the release of a workers compensation reserve.

    第三季護理與醫事專業營收為 5.73 億美元,較去年同期下滑 31%。就季比而言,部門營收下滑 17%,主要受持續的量、工時與計費費率下降趨勢影響。平均計費費率年減 10%,季減 7%。年比量下滑 19%,平均工時下滑 4%。季比量下滑 12%,平均工時下滑 1%。第三季旅行護理(Travel Nurse)營收為 3.84 億美元,較去年同期減少 34%,較上一季減少 20%。本季醫事專業(Allied)營收為 1.68 億美元,年減 12%,季減 8%。第三季護理與醫事專業毛利率為 27.5%,較去年同期提高 50 個基點,較上一季提高 80 個基點。其中有 40 個基點的提升來自於釋放工傷保險準備。

  • Segment operating margin of 14.5% increased 60 basis points year-over-year due to higher gross margin and lower bad debt expense, partially offset by lower SG&A leverage. Sequentially, operating margin decreased 40 basis points as the improvement in gross margin was more than offset by lower SG&A leverage.

    部門營業利益率為 14.5%,年增 60 個基點,主要因毛利率較高與呆帳費用較低,但部分被 SG&A 槓桿下降所抵銷。就季比而言,營業利益率下降 40 個基點,因毛利率改善被 SG&A 槓桿下降所抵銷且影響更大。

  • For our Physician and Leadership Solutions segment, third quarter revenue of $160 million was down 9% year-over-year and sequentially. The decrease in revenue year-over-year was primarily due to lower performance within interim and search, while sequentially the revenue fall was driven by lower volumes across all 3 businesses in the segment. Locum Tenens revenue in the quarter was $113 million, a 6% increase from the prior year period. Sequentially, Locum's revenue was down 8%, driven by lower volume primarily in non-CRNA positions. Interim leadership revenue of $31 million decreased 35% from the prior year period and 15% from the prior quarter. Search revenue of $16 million was down 25% from the prior year and down 10% sequentially. Interim and Search revenue were down year-over-year mainly due to lower demand as cost management remains a prominent factor for health care assistance.

    在醫師與領導力解決方案部門方面,第三季營收為 1.60 億美元,年減 9%,亦較上一季下滑 9%。年比營收下降主要因臨時管理(interim)與搜尋(search)表現較弱;季比營收下滑則是因部門內三項業務的量均下降。本季短期代班醫師(Locum Tenens)營收為 1.13 億美元,較去年同期增加 6%。就季比而言,Locum 營收下滑 8%,主要因非 CRNA 職位的量下降所致。臨時領導(interim leadership)營收為 3,100 萬美元,較去年同期下降 35%,較上一季下降 15%。搜尋(search)營收為 1,600 萬美元,較去年同期下降 25%,較上一季下降 10%。臨時與搜尋營收年比下滑,主要因在醫療機構成本管理仍為重要因素下,需求較低。

  • Gross margin for Physician and Leadership Solutions was 33.4%, down 60 basis points year-over-year, mainly due to an unfavorable revenue mix shift, partially offset by improved gross margin within Locum Tenens. Sequentially, gross margin was down a 170 basis points, primarily due to lower gross margin in Locum Tenens. Segment operating margin was 13.5% which decreased 10 basis points year-over-year. Sequentially, operating margin decreased 150 basis points, primarily due to lower gross margin.

    醫師與領導力解決方案部門毛利率為 33.4%,年減 60 個基點,主要因不利的營收組合轉移(revenue mix shift),部分被短期代班醫師(Locum Tenens)毛利率改善所抵銷。就季比而言,毛利率下降 170 個基點,主要因 Locum Tenens 毛利率較低。部門營業利益率為 13.5%,年減 10 個基點。就季比而言,營業利益率下降 150 個基點,主要因毛利率較低。

  • Technology and Workforce Solutions revenue for the third quarter was $120 million, down 11% year-over-year and 4% sequentially. Language services revenue of $66 million, increased 20% year-over-year and 4% sequentially. VMS revenue for the quarter was $38 million, a decrease of 37% year-over-year and 18% sequentially.

    第三季科技與人力解決方案(Technology and Workforce Solutions)營收為 1.20 億美元,年減 11%,季減 4%。語言服務(Language services)營收為 6,600 萬美元,年增 20%,季增 4%。本季 VMS 營收為 3,800 萬美元,年減 37%,季減 18%。

  • Segment gross margin was 65%, down from 75.6% in the prior year period, primarily due to an unfavorable revenue mix shift and lower gross margin in language services. Sequentially, gross margin fell 170 basis points as margin improvement within language services was more than offset by the revenue mix shift.

    部門毛利率為 65%,低於去年同期的 75.6%,主要因不利的營收組合轉移以及語言服務毛利率較低。就季比而言,毛利率下降 170 個基點,因語言服務的毛利率改善被營收組合轉移所抵銷且影響更大。

  • Segment operating margin in the third quarter was 42.1% compared with 52.7% in the prior year and 44.1% in the prior quarter. The decrease in operating margin was driven by lower gross margin compared with the prior periods.

    第三季部門營業利益率為 42.1%,去年同期為 52.7%,上一季為 44.1%。營業利益率下降主要因毛利率較前期為低。

  • Third quarter consolidated adjusted EBITDA was $134 million, a decrease of 27% year-over-year and 17% sequentially. Adjusted EBITDA margin of 15.7% was down 30 basis points year-over-year and 60 basis points sequentially. The favorable items that impacted SG&A expenses and the workers comp reserve release increased adjusted EBITDA margin by 90 basis points.

    第三季合併調整後 EBITDA 為 1.34 億美元,年減 27%,季減 17%。調整後 EBITDA 利潤率為 15.7%,年減 30 個基點,季減 60 個基點。影響 SG&A 費用的有利項目以及釋放工傷保險準備,使調整後 EBITDA 利潤率提高 90 個基點。

  • Third quarter net income was $53 million, down 43% year-over-year and down 13% sequentially. Third quarter GAAP diluted earnings per share was $1.39. Adjusted earnings per share for the quarter was $1.97 compared to $2.57 in the prior year period and $2.38 in the prior quarter. Day sales outstanding was 61 days, 8 days higher than the prior quarter and 2 days higher than the prior year, primarily due to expected billing delays with the implementation of a new back office system in the quarter.

    第三季淨利為 5,300 萬美元,年減 43%,季減 13%。第三季 GAAP 稀釋每股盈餘為 1.39 美元。本季調整後每股盈餘為 1.97 美元,去年同期為 2.57 美元,上一季為 2.38 美元。應收帳款週轉天數(DSO)為 61 天,較上一季增加 8 天,較去年增加 2 天,主要因本季導入新的後台系統而出現預期中的開立帳單延遲。

  • Operating cash flow for the third quarter was $172 million and capital expenditures were $30 million. As of September 30, we had cash and equivalents of $29 million, long-term debt of $945 million including a $95 million draw on a revolving line of credit and a net leverage ratio of 1.4x to 1.

    第三季營運現金流為1.72億美元,資本支出為3,000萬美元。截至9月30日,我們持有現金及約當現金2,900萬美元,長期負債為9.45億美元,其中包括循環信用額度已動用9,500萬美元,淨槓桿比率為1.4倍(1.4x)對1。

  • Moving to fourth quarter 2023 guidance, we project consolidated revenue to be in a range of $790 million to $810 million, down 28% to 30% from the prior year period. Guidance does not include the pending acquisition of MSDR, which we expect to close later this quarter. Gross margin is projected to be between 32.3% and 32.8%. Reported SG&A expenses are projected to be 21% to 21.5% of revenue. Operating margin is expected to be 5.9% to 6.5% and adjusted EBITDA margin is expected to be 12.5% to 13%. Sequentially, adjusted EBITDA margin is expected to be lower due to lower gross margin from a revenue mix shift toward lower margin businesses and less leverage over SG&A with lower revenue. Additional fourth quarter guidance details can be found in today's earnings release.

    轉到2023年第四季展望,我們預估合併營收將介於7.90億至8.10億美元,較去年同期下降28%至30%。本指引未包含尚待完成的MSDR收購案,我們預期將於本季稍晚完成交割。毛利率預估介於32.3%至32.8%。列報的SG&A費用預估為營收的21%至21.5%。營業利益率預期為5.9%至6.5%,調整後EBITDA利潤率預期為12.5%至13%。就季比而言,調整後EBITDA利潤率預期將較低,原因在於營收組合轉向較低毛利業務導致毛利率下降,以及在營收較低的情況下SG&A的槓桿效益較小。更多第四季指引細節請參閱今日的財報新聞稿。

  • Now, operator, please open the call for questions.

    現在,接線員,請開放提問。

  • Operator

    Operator

  • (Operator Instructions) Our first question comes from the line of Trevor Romeo of William Blair.

    (接線員指示)我們的第一個問題來自William Blair的Trevor Romeo。

  • Trevor Romeo

    Trevor Romeo

  • First one, just on the Travel Nurse and Allied business. I think we're all just kind of trying to find out where the bottom is for the market. I think you talked about fourth quarter reflecting a tapering of that downtrend. I guess, as you see it here, do you think the Q4 run rate will be the trough? And are there any data points you can point to that kind of give you confidence in that stabilization?

    第一個問題,關於Travel Nurse與Allied業務。我想大家都在試著找出市場的底部在哪裡。你們提到第四季反映了該下行趨勢的趨緩。我想問的是,以你們目前的觀察,你們認為第四季的run rate會是谷底嗎?另外,有沒有任何數據點可以支持你們對穩定化的信心?

  • Caroline Sullivan Grace - President, CEO & Director

    Caroline Sullivan Grace - President, CEO & Director

  • Trevor, thanks for the question. And I know we talked a bit about this in some of the opening comments. Let me frame out a bit of what we're seeing from clients in the market and then I'll let Jeff fill in a little bit with some of the questions about what we see in Q4 and potentially going into the early part of next year.

    Trevor,謝謝你的問題。我知道我們在開場的一些評論中也談到了一點。讓我先概述一下我們從客戶與市場端看到的情況,接著再請Jeff補充一些關於我們對第四季以及可能延伸到明年初的看法。

  • We're at a point with clients where it really is client by client where they are. I think there's a number of public company CEO comments over the past week that have supported the tremendous progress that the health care systems have made in replacing their permanent workforce throughout the course of this year. And we certainly have both partnering with our clients on that but seeing that. And so, if you look at the travel piece, we have clients who really have progressed to the point that they're now talking about how do I support future volumes and we have clients who still have some work to do in getting their contingent labor back to more normalized levels.

    我們目前與客戶的狀況,確實是因客戶而異。我認為過去一週有不少上市公司CEO的評論,支持醫療照護體系在今年逐步以永久人力取代的過程中取得了非常大的進展。我們當然也在與客戶合作推動這件事,同時也看到了這樣的變化。因此,如果看travel這一塊,我們有些客戶已經進展到開始討論如何支援未來的量能;也有些客戶仍需要在將其臨時人力(contingent labor)拉回更正常化水準方面做一些工作。

  • Broadly speaking, we think that the industry will be back to by the end of this year what we would consider more normalized levels. I think that's reflected in some of the guidance that we gave about traveler volumes. In Q4, the bill rates is slightly different, so what I would say is, we've seen tremendous progress getting back to what we would consider more normal rates as we exit this year but we still have some clients who are working on what their overall levels are.

    整體而言,我們認為到今年底,產業將回到我們所認定的較正常化水準。我想這也反映在我們對旅護士量(traveler volumes)的部分指引中。第四季的計費費率(bill rates)略有不同,因此我會說,隨著今年接近尾聲,我們已看到在回到我們認為較正常的費率方面取得了很大進展,但仍有一些客戶正在調整其整體用量水準。

  • Jeff?

    Jeff?

  • Jeffrey R. Knudson - CFO, CAO & Treasurer

    Jeffrey R. Knudson - CFO, CAO & Treasurer

  • Yes, Trevor, I would just add. When we think about the fourth quarter, I would say, on-balance the winter needs orders played out as we thought they would. There was a slight headwind from some later start dates and lower bill rates than we had expected. And then within the client dynamics, that Cary spoke about, I would say that most of our clients, we did see sequential increases in Q4 over Q3 and their utilization, but there were several large clients that were continuing to reduce utilization with the progress they've made on hiring and retention. So, as we just look at the pace, where they're pacing relative to those that behave that as we thought they would, there could be room for them to improve further in the first quarter and reduce their utilization, which could lead to Nurse and Allied being flat to slightly down in Q1 over Q4.

    是的,Trevor,我補充一下。當我們看第四季時,我會說整體而言,冬季需求訂單(winter needs orders)的表現大致如我們預期。不過,因部分較晚的到職日期以及低於我們預期的計費費率,帶來了些微逆風。再就Cary提到的客戶動態而言,我會說我們大多數客戶在第四季相較第三季,其使用率(utilization)呈現季增;但也有幾家大型客戶,隨著其在招募與留任方面取得進展,仍持續降低使用率。因此,若僅看其進度,相較於那些如我們預期般表現的客戶,這些客戶在第一季可能還有進一步改善並降低使用率的空間,這可能導致Nurse與Allied在第一季相較第四季持平至小幅下滑。

  • From a bill rate standpoint, in Q2 and Q3, we saw sequential declines in the bill rate of about 7%. The expectation is that, bill rates will be down 4% in Q4 over Q3 and that could continue to move low-single digits moving into next year downward.

    就計費費率而言,在第二季與第三季,我們看到計費費率約有7%的季減。預期第四季相較第三季計費費率將下降4%,而進入明年後,可能仍會以低個位數的幅度持續下滑。

  • Trevor Romeo

    Trevor Romeo

  • Okay. That was helpful. And then for my follow up, I wanted to touch on the MSDR deal a bit more. Could you maybe tell us any more about how that business has grown historically beyond just this year, I think, looks like about 50% growth based on your press release? And what kind of growth you'd expect from MSDR going forward and maybe how much opportunity you'd have for both revenue and cost synergies in that deal?

    好的,這很有幫助。接著我的追問想再多談一些MSDR這筆交易。你們是否能再多分享一些該業務在今年以外的歷史成長情況?我想依你們新聞稿看起來今年大約成長50%。另外,你們預期MSDR未來的成長如何?以及在這筆交易中,你們在營收與成本綜效方面大概有多少機會?

  • Caroline Sullivan Grace - President, CEO & Director

    Caroline Sullivan Grace - President, CEO & Director

  • Yes, let me give you a little bit of how we think about MSDR, particularly in the context of our broader AMN business. I know we have talked for some time about Locums being one of our MNA priorities. And so, we love the market, we love the growth opportunity that we see both in terms of just our clients very focused on revenue growth, but also just some of the workforce structural changes that you see within the physician space making more than interested in a Locums-type of role.

    好的,我先談一下我們如何看待MSDR,特別是放在我們更廣泛的AMN業務脈絡下。我知道我們談了一段時間,Locums一直是我們MNA的優先事項之一。因此,我們喜歡這個市場,也喜歡我們所看到的成長機會:一方面客戶非常聚焦於營收成長;另一方面,在醫師領域的人力結構性變化,也讓更多人對Locums類型的角色更感興趣。

  • For MSDR, in particular, and I'll let Jeff talk a little bit about what we've seen in terms of some of the numbers and certainly, they've had very strong historical growth. What's very compelling to us beyond their profile across a number of specialties that we are not as strong in is that, we have really, we think, 2 significant synergy opportunities. The first one is, while they have a consolidated back-end platform, they still have some opportunities between their 2 organizations for front-end synergies that we're going to be focused on in 2024. And the second part, Trevor is, if you look at our Locums business today, we are more constrained by supply than demand. So what's very attractive, both for MSDR and for AMN, is to be able to put the strength of their supply, particularly around a number of very key specialties into our already existing demand.

    就MSDR而言,我會先請Jeff談一些我們看到的數字;他們確實有非常強勁的歷史成長。對我們來說,除了他們在多個我們相對不那麼強勢的專科領域所具備的布局之外,更吸引人的是我們認為有兩個重要的綜效機會。第一,他們雖然已有整合的後端平台,但在其兩個組織之間,前端仍有一些綜效機會,我們將在2024年聚焦推動。第二點,Trevor,如果你看我們目前的Locums業務,我們的限制更多在供給而非需求。因此,對MSDR與AMN都非常有吸引力的是,能把他們在供給端的優勢——特別是在若干關鍵專科——導入我們既有的需求之中。

  • Operator

    Operator

  • (Operator Instructions) Next question comes from the line of Kevin Fischbeck of Bank of America.

    (接線員指示)下一個問題來自美國銀行(Bank of America)的Kevin Fischbeck。

  • Kevin Mark Fischbeck - MD in Equity Research

    Kevin Mark Fischbeck - MD in Equity Research

  • I guess, clearly, the market is going through some pretty significant changes right now and it's hard to kind of see where share is moving. But, I guess, from your perspective, do you feel like you guys are gaining share or losing share over the past couple of quarters into Q4?

    我想很明顯地,市場目前正經歷一些相當重大的變化,也很難看出市占率的移動方向。不過,從你們的角度來看,你們覺得過去幾個季度一路到第四季,你們是在提升市占還是在流失市占?

  • Caroline Sullivan Grace - President, CEO & Director

    Caroline Sullivan Grace - President, CEO & Director

  • Yes, Kevin, let me kind of take it in 2 parts that I've talked about both of these in the past couple quarters because I think that these are the 2 elements that we look at relative to the overall share piece. So the first one is, we talked a lot about the industry had this pent up RFP cycle for clients coming out of 3 years of crisis management. That's not AMN phenomena, that was happening across the industry. So if I look at where we are in that RFP cycle for clients, we're at the tail end. So we still have a couple of clients both this quarter and into next quarter that we would consider kind of the tail end of that bigger COVID RFP cycle. If you look at our RFPs going into next year, it is a significantly smaller number of clients that would be going into RFP. So that's been the first piece that we've been very focused on, particularly coming out of COVID and ensuring that we were aligned and realigned with our clients coming out of really a generational crisis.

    是的,Kevin,我把它分成兩個部分來談;因為我在過去幾個季度也談過這兩點,我認為這是我們用來觀察整體市占的兩個要素。第一點是,我們談到產業在經歷了三年的危機管理後,客戶累積了一波待處理的RFP週期。這不是AMN特有的現象,而是整個產業都在發生。因此,如果我看我們在客戶RFP週期中的位置,我們已接近尾聲。本季以及到下季,我們仍有幾個客戶可視為那一波較大的COVID RFP週期的尾端。如果看我們進入明年的RFP,將進入RFP的客戶數量會顯著較少。這一直是我們非常聚焦的第一個面向,特別是在COVID之後,確保我們與客戶的合作關係能夠對齊並重新對齊,走出這場可說是世代性的危機。

  • The second piece is on sales, which is incredibly important around just -- not just retaining your clients but growing. I talked last quarter about how we have turned on sales after it was really effectively shut off during COVID and the growth that we saw in our pipeline, which was quite significant, 300%, if we looked at kind of year-over-year. Quarter-to-quarter, we have seen our pipeline continue to expand. That expansion is across MSP, VMS and all of our other solutions. At the same time, that we have been continuing to build the sales pipeline, we've seen the pipeline progress. So if I look at the indicators of where our share position is going, they are positive.

    第二個部分是銷售,這在當下極其重要——不僅是留住客戶,還要實現成長。我在上個季度談到,我們在 COVID 期間銷售幾乎被有效地關閉之後,已重新啟動銷售,以及我們在管線中看到的成長相當顯著;若以年對年來看,大約是 300%。以季對季來看,我們看到管線持續擴大。這種擴張涵蓋 MSP、VMS 以及我們所有其他解決方案。同時,在我們持續建立銷售管線的過程中,我們也看到管線在推進。因此,如果我看我們市占位置走向的指標,它們是正面的。

  • Kevin Mark Fischbeck - MD in Equity Research

    Kevin Mark Fischbeck - MD in Equity Research

  • Okay. Could you just -- I guess, those 2 statements felt a little bit [integrous] to me. If you're saying you're largely through the RFP, but your sales pipeline is high. So what's the difference between the sales pipeline and then the RFP? Was that AMN comment versus industry comment or...

    好的。你能不能——我想,這兩個說法對我來說有點[不太一致]。如果你說你們基本上已經快走完 RFP,但你們的銷售管線又很高。所以銷售管線和 RFP 之間的差別是什麼?那是 AMN 的評論還是產業的評論,或是……

  • Caroline Sullivan Grace - President, CEO & Director

    Caroline Sullivan Grace - President, CEO & Director

  • Yes, I'm sorry, Kevin. So if we look at growth, one is, are you keeping all of your clients through this post-COVID RFP cycle? Thing 1. Thing 2 is, are you continuing to grow on top of that? So, we are doing both simultaneously. How are we ensuring that we get through this RFP cycle have a solid base with clients? And then how do we continue to grow off of that, both with new clients and names, as well as expanding existing client relationships?

    是的,Kevin,不好意思。若我們看成長,一個是:在這個後 COVID 的 RFP 週期中,你是否能留住所有客戶?這是第一點。第二點是:在此基礎之上,你是否還能持續成長?所以我們是同時在做這兩件事。我們如何確保順利度過這個 RFP 週期、與客戶維持穩固的基礎?然後我們如何在此之上持續成長——不論是透過新客戶與新名稱,或是擴大既有客戶關係?

  • Kevin Mark Fischbeck - MD in Equity Research

    Kevin Mark Fischbeck - MD in Equity Research

  • Okay. And then, can you talk a little bit about the types of services that are being increasingly asked for? Are we seeing a shift back to MSPs? Or are we still looking at VMS or partial solutions? What are we looking at in this new sales cycle?

    好的。那你能不能談談越來越常被要求的服務類型?我們是否看到回到 MSP 的轉變?還是我們仍在看 VMS 或部分解決方案?在這一輪新的銷售週期中,我們看到的是什麼?

  • Caroline Sullivan Grace - President, CEO & Director

    Caroline Sullivan Grace - President, CEO & Director

  • We're seeing both. So we are seeing a healthy increase in our MSP pipeline. We are also seeing a healthy increase in our VMS pipeline. So the answer is, if you look at the growth that we've had and I say particularly over the past 2 to 3 quarters in our sales pipeline, it's coming from both MSP and VMS solutions.

    兩者都有。所以我們看到 MSP 管線有健康的增加;我們也看到 VMS 管線有健康的增加。因此答案是:如果你看我們的成長,尤其是我說過去 2 到 3 個季度銷售管線的成長,它同時來自 MSP 與 VMS 解決方案。

  • Kevin Mark Fischbeck - MD in Equity Research

    Kevin Mark Fischbeck - MD in Equity Research

  • Would you say that -- how does that compare to your current business mix? Is it more shifted to one versus the other?

    你會說——這和你們目前的業務組合相比如何?是否更偏向其中一個而不是另一個?

  • Caroline Sullivan Grace - President, CEO & Director

    Caroline Sullivan Grace - President, CEO & Director

  • It's a good question. I don't know that there's a bias one way or the other. I think that we have become more client-centric in how we approach a new client. And so, we probably had a slight bias towards MSP in the past. And if you look at our approach now, we really look at it and say, we want to participate fully in all of those markets. So, as clients embrace MSP models, we want to be their first choice as clients embrace vendor-neutral or other types of hybrid models, we also want to be their first choice.

    這是個好問題。我不確定是否有偏向某一邊。我認為我們在接觸新客戶時,已變得更以客戶為中心。因此,我們過去可能對 MSP 略有偏好。而如果你看我們現在的做法,我們真的會看著它並說:我們希望在所有這些市場中全面參與。所以,當客戶採用 MSP 模式時,我們希望成為他們的第一選擇;當客戶採用供應商中立或其他類型的混合模式時,我們也希望成為他們的第一選擇。

  • Operator

    Operator

  • (Operator Instructions) Next question comes from the line of Tobey Sommer of Truist Securities.

    (接線員指示)下一個問題來自 Truist Securities 的 Tobey Sommer。

  • Jasper James Bibb - Associate

    Jasper James Bibb - Associate

  • This is Jasper Bibb on for Tobey. Just curious what you're seeing from a bill pay spread perspective? Do you see spreads continuing the narrow into the first quarter of 2024? Or are you starting to see that spread compression stabilize a bit on some of your newer orders?

    我是代替 Tobey 的 Jasper Bibb。想請教你們從帳單支付價差(bill pay spread)的角度看到什麼?你們是否看到價差在 2024 年第一季仍持續收窄?還是你們開始看到在一些較新的訂單上,價差壓縮有些穩定下來?

  • Jeffrey R. Knudson - CFO, CAO & Treasurer

    Jeffrey R. Knudson - CFO, CAO & Treasurer

  • Yes, Jasper, this is Jeff. I would say, if you exclude the workers comp benefit that we received in the third quarter, the midpoint of our gross margin guidance is down about 100 basis points sequentially in Q4 over Q3. That's pretty equally driven, I would say, by a change in business mix shifting to lower margin businesses across certainly PLS and TWS, but we are seeing compression in the bill pay spread just given the lower demand environment on Nurse and Allied and that's a driver of the Q4 over Q3 change. And as we move into next year and certainly the early part of the first 2 quarters of next year, we wouldn't anticipate that to change from a bill pay spread dynamic standpoint.

    是的,Jasper,我是 Jeff。我會說,如果排除我們在第三季收到的工傷保險(workers comp)福利,我們毛利率指引的中位數在第四季相較第三季,序列下降約 100 個基點。我認為這幾乎同等地是由業務組合變化所驅動——轉向較低毛利的業務,主要是在 PLS 和 TWS;但我們也確實看到帳單支付價差的壓縮,因為護理(Nurse)與醫療輔助(Allied)的需求環境較弱,而這是第四季相較第三季變化的驅動因素。展望明年,尤其是明年前兩個季度的前半段,從帳單支付價差的動態來看,我們不預期會有改變。

  • Jasper James Bibb - Associate

    Jasper James Bibb - Associate

  • Okay, got it. Yes, apologies if I missed this, but was there any strike planning or labor disruption work contemplated in the 4Q revenue guide? Like, I know there has been some union action that notable clients the past couple of months, but not sure if that's translated to anything from a revenue perspective.

    好的,了解。是的,如果我漏聽了先道歉,但第四季營收指引中是否納入任何罷工規劃或勞動中斷相關的工作?例如,我知道過去幾個月一些知名客戶有工會行動,但不確定是否在營收面有反映出來。

  • Jeffrey R. Knudson - CFO, CAO & Treasurer

    Jeffrey R. Knudson - CFO, CAO & Treasurer

  • Yes. There's about $2 million of labor disruption revenue embedded in the Q4 guide and that number was right around a $1 million in our Q3 actuals a little less than that. So pretty immaterial on both periods.

    有的。第四季指引中包含約 200 萬美元的勞動中斷營收,而第三季實際值大約是 100 萬美元、略低於此。所以在兩個期間都相當不具重大性。

  • Operator

    Operator

  • (Operator Instructions) Next question comes from the line of Brian Tanquilut of Jefferies.

    (接線員指示)下一個問題來自 Jefferies 的 Brian Tanquilut。

  • Brian Gil Tanquilut - Senior Equity/Stock Analyst

    Brian Gil Tanquilut - Senior Equity/Stock Analyst

  • Cary, I'll just follow up to Kevin's questions earlier. As I think about, cover -- we cover the hospitals, right? And they're all still saying that they're still trying to reduce their use and spend on contract labor. And I know in your prepared remarks, you talked about kind of like a flattening or the stabilization of broader demand. So how should we be thinking about that? And what gives you the confidence that you're not losing a share in this environment?

    Cary,我想延續 Kevin 先前的問題。當我思考——我們覆蓋醫院端,對吧?他們仍然都在說還在努力降低合約勞動(contract labor)的使用與支出。而我知道你在事先準備的發言中提到,整體需求似乎正在趨於持平或穩定。我們應該如何看待這件事?以及在這樣的環境下,是什麼讓你有信心你們沒有流失市占?

  • Caroline Sullivan Grace - President, CEO & Director

    Caroline Sullivan Grace - President, CEO & Director

  • No, I guess, what we have anecdotally heard from others is that, what we've been experiencing is similar to what others are experiencing our industry. Obviously, we work very closely with a number of suppliers broadly across a number of different clinical roles. And so, as we work with our clients around how they think about rebuilding a sustainable workforce. To your point, Brian, there was a significant focus around how do you bring down contingent labor, both in terms of the size, but also if you looked at the marginal cost of that labor relative to permanent hires, there was a historically high difference between that. So the focus I think was both on numbers, but it was also because you were at a point where you had a dislocation in terms of the marginal cost.

    不,我想我們從其他人那裡零星聽到的是:我們所經歷的情況與產業中其他人所經歷的相似。顯然,我們與許多供應商密切合作,涵蓋多種不同的臨床職務。因此,當我們與客戶合作、討論他們如何重建可持續的人力結構時——如你所說,Brian——先前有一個很大的重點在於如何降低臨時/派遣人力(contingent labor),不僅是規模,還包括如果你看這類人力的邊際成本相對於正式聘用(permanent hires),兩者之間的差距在歷史上非常高。所以我認為焦點一方面在數量,但另一方面也因為你當時處於邊際成本出現錯位(dislocation)的狀態。

  • If you look at what has happened subsequently, you've seen the marginal cost, partially because the marginal cost of a permanent hire has gone up, the labor inflation, but also the cost of contingent labor has gone down. As systems look at how they're going to really manage and be able to staff a cost-effective full mix, it has become much more cost-effective for them to bring in contingent labor for the Flex. Now, is that true for every client? No, there are some clients that are still at relatively high contingent labor costs. There are other clients and some have been public about this even more recently who they're at a point where they look at it and say, "Hey, I need to actually build back volume, and I can do this in a more cost-effective way". So there's not a one-size-fits-all answer for a client. We have clients who are in different places. We have seen, to Jeff's earlier comment, a number of our clients start to actually go back up, but we still have some very large clients who have targets that they would want to bring it down a little bit from where they are now.

    如果你看之後發生的事情,你會看到邊際成本——部分是因為正式聘用的邊際成本上升(勞動通膨),但同時臨時/派遣人力的成本也下降了。當醫療系統在思考如何真正管理並以具成本效益的方式配置完整的人力組合時,對他們而言,為了彈性(Flex)引進臨時/派遣人力已變得更具成本效益。那這對每個客戶都成立嗎?不,有些客戶的臨時/派遣人力成本仍相對偏高。也有其他客戶——而且有些甚至最近也公開談到——他們已到了一個階段,會看著它並說:「嘿,我其實需要把量拉回來,而我可以用更具成本效益的方式做到。」所以對客戶而言沒有一體適用的答案。我們有處於不同階段的客戶。正如 Jeff 先前的評論,我們已看到一些客戶開始回升,但我們仍有一些非常大型的客戶有目標,希望能從目前水準再降低一些。

  • Brian Gil Tanquilut - Senior Equity/Stock Analyst

    Brian Gil Tanquilut - Senior Equity/Stock Analyst

  • Okay. That makes sense. And then maybe, Jeff, as I think about your fourth quarter guidance, right, so midpoint $800 million of revenue, you gave the EBITDA margin there. So, just a little over $100 million of EBITDA for Q4. Is that the right jumping off point to use? I mean, annualize that and then put a growth rate on top of that? And then what are the other moving parts that we need to be thinking about as we think about 2024? I know you called out some of the, what do you call it, discretionary bonuses that were not in the back half of 2023. So just trying to get any help, but you can share with us as we try to model '24.

    好的。這很合理。那接著可能問 Jeff,當我思考你們第四季指引時——中位數 8 億美元營收,你也給了 EBITDA 利潤率。所以第四季 EBITDA 大概略高於 1 億美元。這是否是用來作為起點的正確方式?也就是把它年化,然後再在上面加一個成長率?那在我們思考 2024 年時,還有哪些其他變動因素需要考量?我知道你提到 2023 年下半年沒有一些——你怎麼稱呼它——酌情獎金(discretionary bonuses)。只是想在我們嘗試建模 2024 年時,看看你能否提供任何協助。

  • Jeffrey R. Knudson - CFO, CAO & Treasurer

    Jeffrey R. Knudson - CFO, CAO & Treasurer

  • Yes, Brian. So I'll list out a couple of tailwinds and headwinds off of that Q4 exit rate. So, certainly on the tailwind side, we would expect continued growth in language services, moving into next year that business was up 20% year-over-year in Q3. We'll obviously have the tailwind in Locums from the MSDR acquisition, which we spoke about earlier. And then we saw the opportunity to capitalize on a pretty large sales pipeline. I would say, just given ramp and other things, any new client wins would probably impact the second half of '24, much more so than the first half. And then, we still do have the opportunity to improve our internal capture within Nurse and Allied. We're still a couple 100 basis points below pre-pandemic norms on that side.

    是的,Brian。所以我會根據第四季(Q4)退出水準(exit rate)列出幾項順風與逆風。首先在順風方面,我們預期語言服務將持續成長,進入明年該業務在第三季(Q3)年增20%。此外,我們也會受惠於先前提到的MSDR收購案,為Locums帶來順風。再者,我們看到有機會把握相當龐大的銷售管線。我會說,考量到爬坡期(ramp)及其他因素,任何新客戶的得標大概會在2024年下半年帶來影響,遠多於上半年。最後,我們仍有機會提升在Nurse and Allied內部的捕捉率(internal capture)。在那一塊,我們仍比疫情前的常態水準低了約200個基點。

  • From a headwind standpoint, we talked about where certain clients are and that there could be further reductions in Q1 over Q4 levels. And then within Nurse and Allied, we will have an impact on our international nurse business next year from Visa retrogression. That will, again, disproportionately impact the back half of next year, but there will start to be impact in Q1 and Q2. We would anticipate that business to be down about $70 million on the top line year-over-year next year and that will also pose a 30 basis point to 40 basis point headwind to Nurse and Allied gross margins just from a mix standpoint. And then additionally, just given the performance this year, we do have very low levels of incentive comp in the Q4 run rate and that will be about $5 million to $6 million of additional SG&A moving into next year per quarter that's not in Q4.

    從逆風的角度來看,我們談到某些客戶目前的狀況,第一季(Q1)相較第四季(Q4)水準可能還會進一步下滑。此外,在Nurse and Allied方面,明年我們的國際護理業務將受到簽證排期倒退(Visa retrogression)的影響。同樣地,這將對明年下半年造成較不成比例的影響,但在第一季與第二季(Q2)就會開始出現影響。我們預期該業務明年營收(top line)年減約7,000萬美元,且僅就組合(mix)因素而言,也會對Nurse and Allied毛利率帶來約30至40個基點的逆風。另外,考量今年的表現,我們在第四季的運行水準中,獎勵性薪酬(incentive comp)水準非常低;而進入明年後,每季將增加約500萬至600萬美元的SG&A費用,這部分並未包含在第四季之中。

  • Brian Gil Tanquilut - Senior Equity/Stock Analyst

    Brian Gil Tanquilut - Senior Equity/Stock Analyst

  • Jeff, if I add all that, I mean, are you still expecting growth in EBITDA next year?

    Jeff,如果我把這些都加總起來,你們明年仍預期EBITDA會成長嗎?

  • Jeffrey R. Knudson - CFO, CAO & Treasurer

    Jeffrey R. Knudson - CFO, CAO & Treasurer

  • Yes. I mean, I think with just -- I mean, with the MSDR acquisition alone, yes, there would be growth. But off of the Q4 run rate in Nurse and Allied, again, if it's flattish to slightly down in Q1 then we would expect Q2 and Q3 to be seasonally lower off that Q1 base next year.

    是的。我是說,我認為僅就MSDR收購案本身而言,就會帶來成長。但以Nurse and Allied第四季的運行水準來看,如果第一季(Q1)持平到小幅下滑,那麼明年第二季(Q2)與第三季(Q3)將會在該第一季基礎上呈現季節性走低。

  • Operator

    Operator

  • (Operator Instructions) Next question comes from the line of Jeff Silber of BMO Capital Markets.

    (接線員指示)下一個問題來自BMO Capital Markets的Jeff Silber。

  • Unidentified Analyst

    Unidentified Analyst

  • Ryan on for Jeff. Just looking at some of the industry data, the NCLEX pass rates up this year, some of the Visa stuff you just mentioned and then the burnout, how do you kind of triangulate those different factors for the outlook on supply governance next year?

    我是Ryan,代Jeff提問。從一些產業數據來看,今年NCLEX通過率上升、你剛提到的一些簽證因素,以及倦怠(burnout)問題,你們如何綜合(triangulate)這些不同因素,來看明年供給端治理(supply governance)的展望?

  • Caroline Sullivan Grace - President, CEO & Director

    Caroline Sullivan Grace - President, CEO & Director

  • Yes, a couple of things on supply, if we -- I'm going to split out Nurse and Allied with Locum. So if we look at Nurse and Allied supplies, so we look at just applications that we get, we are up significantly from pre-COVID levels. So depending on kind of what area, I think, 30% to 50% above. And so, we still see very healthy supply. Part of the burnout challenge, it actually -- these types of roles become attractive to clinicians who still want to stay and participate in patient care, but want more control over how they do that.

    是的,關於供給端有幾點——我會把Nurse and Allied與Locum分開來談。若看Nurse and Allied的供給,也就是我們收到的申請量,相較COVID之前的水準已顯著增加。依不同領域而定,我認為大約高出30%到50%。因此,我們仍看到非常健康的供給。至於倦怠的挑戰,其實——這類型的職務對仍想留在臨床、參與病患照護,但希望更能掌控自己如何提供照護的臨床人員而言,反而更具吸引力。

  • From a Locums standpoint, we've had strong demand. You can take that year-over-year, you can take it since pre-COVID. And so, we are looking for more supply. And I would say, that's true of the entire industry. So, as much as we've talked about the nursing shortage and nursing burnout, the physician numbers are actually marginally worse. And so, that supply we think is going to be one that is -- MSDR is going add a lot of supply for us in that space. But it's something that we think is going to make the Locums business attractive, particularly as we can keep more positions in, maybe in roles that they can have more control over.

    從Locums的角度來看,我們的需求一直很強勁,不論是年對年比較,或是與COVID之前相比皆是如此。因此,我們正在尋找更多供給。我會說,這也是整個產業的共同情況。所以,儘管我們談了很多護理人力短缺與護理倦怠,醫師的人數其實邊際上更糟。因此,我們認為這個供給會是——MSDR將在該領域為我們增加大量供給。但我們也認為,這會讓Locums業務更具吸引力,特別是當我們能保留更多職缺,或許是在他們能更有掌控度的角色上。

  • Unidentified Analyst

    Unidentified Analyst

  • Got it. And then just on the physician bill rates, I know you put out a report recently about higher salaries for doctors. Would you expect the trajectory of the bill rate increase over the next couple years or so to mirror what we saw in Nurse? Or it would be a little bit more gradual on the way up and down?

    了解。再問一下醫師的計費費率(physician bill rates),我知道你們最近發布了一份報告,提到醫師薪資更高。你們是否預期未來幾年計費費率上升的軌跡會像我們在護理端看到的那樣?還是上升與回落會更為漸進?

  • Jeffrey R. Knudson - CFO, CAO & Treasurer

    Jeffrey R. Knudson - CFO, CAO & Treasurer

  • We would expect -- if we just look at our RDF trends in Locums this year that, that would probably moderate going into 2024 than where we were at this year in terms of year-over-year increases.

    我們預期——如果只看我們今年在Locums的RDF趨勢,那麼進入2024年後,年對年增幅應該會比今年的水準更為趨緩。

  • Operator

    Operator

  • (Operator Instructions) Next question comes from the line of Andre Childress of Baird. Okay. I see Andre online, if you could make sure you're unmuted.

    (接線員指示)下一個問題來自Baird的Andre Childress。好的,我看到Andre在線上,請確認你已解除靜音。

  • Caroline Sullivan Grace - President, CEO & Director

    Caroline Sullivan Grace - President, CEO & Director

  • Maybe we'll come back to Andre.

    也許我們稍後再回到Andre。

  • Operator

    Operator

  • Okay. Andre, if you could rejoin using the Call Me feature, we may be able to address your question.

    好的,Andre,如果你可以使用「Call Me」功能重新加入,我們或許就能回答你的問題。

  • Seeing no questions, additional questions at this time, I'll go ahead and hand the call back over to Cary Grace, President and Chief Executive Officer. Please go ahead.

    目前沒有問題、也沒有其他問題的情況下,我將把電話交回給總裁兼執行長Cary Grace。請繼續。

  • Caroline Sullivan Grace - President, CEO & Director

    Caroline Sullivan Grace - President, CEO & Director

  • So, thank you on behalf of our entire AMN team, who have the privilege of working with our clients and clinicians every day to positively impact health care. We thank all of you for your interest in AMN.

    因此,我代表我們整個AMN團隊向各位致謝;我們每天都有幸與客戶及臨床人員合作,為醫療照護帶來正向影響。也感謝各位對AMN的關注。

  • Operator

    Operator

  • All right. Thank you for your participation in today's conference. This does conclude the program. You may now disconnect.

    好的。感謝各位參與今天的電話會議。至此本次議程結束。您現在可以掛線。